• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity

tetano

Editor, Senior Moderator
J Clin Med


. 2021 Mar 2;10(5):966.
doi: 10.3390/jcm10050966.
Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity


Athanasia Printza[SUP] 1 [/SUP], Mihalis Katotomichelakis[SUP] 2 [/SUP], Konstantinos Valsamidis[SUP] 1 [/SUP], Symeon Metallidis[SUP] 3 [/SUP], Periklis Panagopoulos[SUP] 4 [/SUP], Maria Panopoulou[SUP] 5 [/SUP], Vasilis Petrakis[SUP] 4 [/SUP], Jannis Constantinidis[SUP] 1 [/SUP]



Affiliations

Abstract

A significant proportion of people infected with SARS-CoV-2 report a new onset of smell or taste loss. The duration of the chemosensory impairment and predictive factors of recovery are still unclear. We aimed to investigate the prevalence, temporal course and recovery predictors in patients who suffered from varying disease severity. Consecutive adult patients diagnosed to be infected with SARS-CoV-2 via reverse-transcription-polymerase chain reaction (RT-PCR) at two coronavirus disease-2019 (COVID-19) Reference Hospitals were contacted to complete a survey reporting chemosensory loss, severity, timing and duration, nasal symptoms, smoking, allergic rhinitis, chronic rhinosinusitis, comorbidities and COVID-19 severity. In a cross-sectional study, we contacted 182 patients and 150 responded. Excluding the critically ill patients, 38% reported gustatory and 41% olfactory impairment (74% severe/anosmia). Most of the patients (88%) recovered their sense of smell by two months (median: 11.5 days; IQR: 13.3). For 23%, the olfactory loss lasted longer than a month. There were no significant differences in the prevalence and duration of chemosensory loss between groups of varying COVID-19 severity, and sexes (all p > 0.05). Moderate hyposmia resolved quicker than more severe loss (p = 0.04). Smell and taste loss are highly prevalent in COVID-19. Most patients recover fast, but nearly one out of ten have not recovered in two months.

Keywords: COVID-19; anosmia; chemosensory loss; coronavirus disease-2019; disease severity; gustatory dysfunction; loss of smell; loss of taste; olfactory dysfunction; post-viral; recovery.
 
Back
Top Bottom